Stock 6499 MEDEON BIODESIGN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Medeon Biodesign, Inc.

Equities

6499

TW0006499007

Advanced Medical Equipment & Technology

End-of-day quote Taipei Exchange
Other stock markets
 23:00:00 09/05/2024 BST 		5-day change 1st Jan Change
42.95 TWD +0.23% Intraday chart for Medeon Biodesign, Inc. +0.94% -7.93%
03-08 Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
01-18 Medeologix Inc. announced that it expects to receive TWD 315 million in funding from Medeon Biodesign, Inc. CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 4,623 4,202 3,642 6,592 5,092 4,294
Enterprise Value (EV) 1 3,362 2,521 1,949 4,272 3,743 2,338
P/E ratio 18.2 x -15.9 x -18.9 x 3.17 x -11.7 x -3.56 x
Yield - - - 1.11% 0.86% -
Capitalization / Revenue 6.86 x 9.26 x 5.57 x 95.6 x 17.1 x 21.9 x
EV / Revenue 4.99 x 5.55 x 2.98 x 62 x 12.5 x 11.9 x
EV / EBITDA 14.9 x -12.5 x -49.5 x -9.23 x -8.14 x -2.93 x
EV / FCF 484 x -51.9 x -31.9 x -47.9 x -8.99 x -5.13 x
FCF Yield 0.21% -1.93% -3.13% -2.09% -11.1% -19.5%
Price to Book 2.83 x 2.1 x 1.78 x 1.6 x 1.42 x 1.85 x
Nbr of stocks (in thousands) 79,274 92,162 91,616 91,879 92,017 92,041
Reference price 2 58.31 45.60 39.75 71.75 55.33 46.65
Announcement Date 20/03/19 27/02/20 23/03/21 29/03/22 26/03/23 08/03/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 673.5 453.8 653.9 68.96 298.3 196.3
EBITDA 1 225.1 -202.1 -39.34 -463.1 -459.6 -797.3
EBIT 1 176.3 -257.3 -96.64 -495.6 -487.8 -839.6
Operating Margin 26.17% -56.7% -14.78% -718.69% -163.53% -427.78%
Earnings before Tax (EBT) 1 215.3 -254.1 -113.7 -513.9 -439.1 -1,231
Net income 1 256.6 -262 -192.7 2,078 -433.8 -1,205
Net margin 38.1% -57.74% -29.47% 3,013.75% -145.4% -613.78%
EPS 2 3.201 -2.860 -2.100 22.65 -4.714 -13.09
Free Cash Flow 1 6.942 -48.57 -61.06 -89.12 -416.5 -455.9
FCF margin 1.03% -10.7% -9.34% -129.24% -139.6% -232.28%
FCF Conversion (EBITDA) 3.08% - - - - -
FCF Conversion (Net income) 2.71% - - - - -
Dividend per Share - - - 0.7937 0.4761 -
Announcement Date 20/03/19 27/02/20 23/03/21 29/03/22 26/03/23 08/03/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2022 Q1 2022 Q2 2022 Q3
Net sales 1 9.754 190.5 29.35 41.52
EBITDA - - - -
EBIT 1 -134.9 40.84 -157.1 -183.8
Operating Margin -1,383.02% 21.43% -535.32% -442.55%
Earnings before Tax (EBT) - - - -
Net income - - - -
Net margin - - - -
EPS - - - -
Dividend per Share - - - -
Announcement Date 04/11/21 06/05/22 05/08/22 04/11/22
1TWD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 1,261 1,682 1,693 2,320 1,348 1,955
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 6.94 -48.6 -61.1 -89.1 -416 -456
ROE (net income / shareholders' equity) 13% -14% -6.93% -17.2% -12.7% -42.1%
ROA (Net income/ Total Assets) 6.15% -7.2% -2.07% -8.07% -7.26% -15.5%
Assets 1 4,176 3,637 9,304 -25,760 5,978 7,791
Book Value Per Share 2 20.60 21.70 22.30 44.90 39.10 25.20
Cash Flow per Share 2 4.130 5.120 12.30 7.990 5.260 13.50
Capex 1 51.1 48.9 20.2 8.32 141 55.3
Capex / Sales 7.59% 10.78% 3.08% 12.06% 47.12% 28.17%
Announcement Date 20/03/19 27/02/20 23/03/21 29/03/22 26/03/23 08/03/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
MEDEON BIODESIGN, INC. Stock Medeon Biodesign, Inc.
-7.93% 122M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+11.73% 226B
DANAHER CORPORATION Stock Danaher Corporation
+9.53% 188B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+14.63% 137B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+27.47% 108B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-0.04% 63.19B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.73% 52.26B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+4.86% 51B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+7.72% 43.89B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+7.86% 38.07B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. 6499 Stock
  4. Financials Medeon Biodesign, Inc.